You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our MET (MET) ELISA Kits

Full name:
Met Proto-Oncogene ELISA Kits (MET)
On are 61 Met Proto-Oncogene (MET) ELISA Kits from 17 different suppliers available. Additionally we are shipping MET Antibodies (694) and MET Proteins (52) and many more products for this protein. A total of 833 MET products are currently listed.
AI838057, AUTS9, c-met, HGF, Hgfr, Par4, RCCP2
list all ELISA KIts Gene Name GeneID UniProt
MET 4233 P08581
MET 17295  
MET 24553 P97523

Show all species

Show all synonyms

Top referenced MET ELISA Kits

  1. Human MET ELISA Kit for Sandwich ELISA - ABIN1672788 : Bin, Ma, Xu, Shi: Embryonic hepatocyte transplantation for hepatic cirrhosis: efficacy and mechanism of action. in World journal of gastroenterology : WJG 2012 (PubMed)
    Show all 3 references for ABIN1672788

More ELISA Kits for MET Interaction Partners

Human Met Proto-Oncogene (MET) interaction partners

  1. his review will describe the mechanisms of aberrant c-Met signaling in colorectal cancer and discuss on additional roles for c-Met receptor through crosstalk with other tyrosine kinase (show TXK ELISA Kits) receptors and cell surface proteins in colorectal cancer

  2. This article reviews aberrations in epidermal growth factor receptor (show EGFR ELISA Kits), MET, and ERBB2 (show ERBB2 ELISA Kits), their therapeutic implications, and future directions in targeting these pathways.

  3. This review highlights treatment options, including clinical trials for ROS1 rearrangement, RET fusions, NTRK1 fusions, MET exon skipping, BRAF mutations, and KRAS mutations.

  4. MET amplification and overexpression, assessed by multiple methods, were associated with a worse prognosis in univariate analyses. However, only MET amplification by FISH and Met expression by SRM (show SRM ELISA Kits) were independent prognostic biomarkers.

  5. AZD9291 is the first and only FDA (show FDA ELISA Kits) approved third-generation epidermal growth factor receptor (EGFR (show EGFR ELISA Kits)) tyrosine kinase (show TXK ELISA Kits) inhibitors for T790M-positive advanced non-small cell patients. The resistance to AZD9291 arises after therapy. The mechanisms of resistance to third-generation inhibitors reported to date include the EGFR (show EGFR ELISA Kits) C797S mutation, EGFR (show EGFR ELISA Kits) L718Q mutation, and amplifications of HER-2 (show ERBB2 ELISA Kits), MET, or ERBB2 (show ERBB2 ELISA Kits). [review]

  6. study indicates that tyrosine kinase (show TXK ELISA Kits) signaling in host pre-osteoclasts/osteoclasts is critical for bone destruction induced by tumor cells and that targeting of MET/VEGF receptor (show FLT1 ELISA Kits)/FMS (show CSF1R ELISA Kits) activity makes it a promising therapeutic candidate for the treatment of prostate cancer patients with bone metastasis.

  7. Data identify, for the first time, a novel non-canonical dynamic mode of interaction between Met and the p66 (show POLD3 ELISA Kits) protein isoform of Shc (show SHC1 ELISA Kits) and its effects on rewiring binding effector complexes according to the activation state of the receptor.

  8. Specifically, miR (show MLXIP ELISA Kits)-130a was attenuated in HFD-induced PCa (show FLVCR1 ELISA Kits) progression with MET overexpression. miRNAs thus have implications in the mechanism, prevention and treatment of HFD-induced prostate cancer (PCa (show FLVCR1 ELISA Kits))progression.

  9. We observed that TKI-resistant cells have increased gene and protein expression of EMT (show ITK ELISA Kits) related proteins such as Vimentin (show VIM ELISA Kits), N-Cadherin (show CDH2 ELISA Kits), beta-Catenin (show CTNNB1 ELISA Kits) and Zeb-1 (show ZEB1 ELISA Kits), while expression of E-Cadherin (show CDH1 ELISA Kits), an important cell adhesion molecule (show MCAM ELISA Kits), was suppressed.

  10. PD-L1 expression is positively correlated with c-Met expression in esophageal squamous cell carcinoma

Mouse (Murine) Met Proto-Oncogene (MET) interaction partners

  1. In this paper, we demonstrate a potential biochemical mechanism for such phenomena by showing that c-Met receptors promote the tyrosine phosphorylation of RalGDS (show RALGDS ELISA Kits) at Y752 in its RBD (show CACNA1D ELISA Kits), which blocks the binding of Ras to RalGDS (show RALGDS ELISA Kits).

  2. study demonstrates that co-activation of AKT (show AKT1 ELISA Kits) and c-Met induces hepatocellular carcinoma development that depends on the mTORC1/FASN (show FASN ELISA Kits) pathway.

  3. Molecular and functional studies revealed that ectopic Met expression in limb mesenchyme does not alter HGF (show HGF ELISA Kits) expression patterns and levels, but impairs HGF (show HGF ELISA Kits) bioavailability

  4. miR-206 suppressed c-Met expression in gastric cancer and could function as a potent tumor suppressor in c-Met overexpressing tumors.

  5. Meg3 overexpression in insulinoma cells down-regulated the expression of the protooncogene c-met.

  6. our results support the concept of the acrosome as a lysosome-related organelle and provide evidence for the identification of MET as a tyrosine kinase receptor (show KDR ELISA Kits) that may play a role in fertilization.

  7. We show that a subset of adult calcitonin gene-related peptide (CGRP (show CALCA ELISA Kits))-expressing myenteric neurons produce MET, the receptor for hepatocyte growth factor (show HGF ELISA Kits).

  8. HGF and c-met inhibition by means of a novel monoclonal neutralizing antibody inhibits tumor growth in prostate cancer cells and in mouse xenografts.

  9. facilitates T cell recruitment to the heart via CCR5 (show CCR5 ELISA Kits) receptor by inducing autocrine CCR5 (show CCR5 ELISA Kits) ligand release

  10. C-Met pathway is suggested to contribute to the lymphomagenesis in the MALT lymphoma after H. heilmannii infection.

Cow (Bovine) Met Proto-Oncogene (MET) interaction partners

  1. possible cooperative role of the EGF (show EGF ELISA Kits) and HGF (show HGF ELISA Kits) pathways and indicate that cross-talk between their respective receptors may modulate mammary gland development in the cow

MET Antigen Profile

Antigen Summary

The proto-oncogene MET product is the hepatocyte growth factor receptor and encodes tyrosine-kinase activity. The primary single chain precursor protein is post-translationally cleaved to produce the alpha and beta subunits, which are disulfide linked to form the mature receptor. Various mutations in the MET gene are associated with papillary renal carcinoma. Two transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with MET

  • met proto-oncogene (MET) Elisa Kit
  • met proto-oncogene (Met) Elisa Kit
  • met proto-oncogene (hepatocyte growth factor receptor) (MET) Elisa Kit
  • AI838057 Elisa Kit
  • AUTS9 Elisa Kit
  • c-met Elisa Kit
  • HGF Elisa Kit
  • Hgfr Elisa Kit
  • Par4 Elisa Kit
  • RCCP2 Elisa Kit

Protein level used designations for Met Proto-Oncogene (MET) ELISA Kits

HGF receptor , HGF/SF receptor , SF receptor , hepatocyte growth factor receptor , met proto-oncogene tyrosine kinase , proto-oncogene c-Met , scatter factor receptor , tyrosine-protein kinase Met , c-Met , HGF receptor c-Met

4233 Homo sapiens
17295 Mus musculus
24553 Rattus norvegicus
403438 Canis lupus familiaris
280855 Bos taurus
654328 Sus scrofa
100126565 Oryctolagus cuniculus
Selected quality suppliers for MET (MET) ELISA Kits
Did you look for something else?